Scopus BioPharma Inc. (SCPS)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Operating Cash Flow | -8.12 Million | -11.42 Million | -2.52 Million | -2.12 Million | -747.31 Thousand |
| Net Income | -11.71 Million | -26.95 Million | -10.86 Million | -2.68 Million | -685.96 Thousand |
| Depreciation & Amortization | 1728.00 | 1500.00 | 1440.00 | 664.00 | - |
| Deferred income taxes | - | -1.45 Million | - | - | - |
| Stock-based compensation | 351.72 Thousand | 669.6 Thousand | 290.4 Thousand | 213.64 Thousand | 69.64 Thousand |
| Change in working capital | 3.23 Million | 2.84 Million | 1.14 Million | 355.23 Thousand | -130.99 Thousand |
| Other non-cash items | - | 13.47 Million | 6.91 Million | 89.15 Thousand | - |
| Investing Cash Flow | -1552.00 | -1999.00 | - | -4251.00 | - |
| Investments in PPE | -1552.00 | -1999.00 | - | -4251.00 | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 241.94 Thousand | 17.55 Million | 4.35 Million | 2.18 Million | 597.63 Thousand |
| Debt repayment | - | -104.5 Thousand | -2.18 Million | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 20.1 Million | 3.27 Million | 1.77 Million | 538.48 Thousand |
| Other Financing Activities | 241.94 Thousand | -2.43 Million | 1.07 Million | 407.21 Thousand | 59.14 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 3 Billion | 2.94 Billion | 1.18 Million | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -3 Billion | -2.93 Billion | -35.24 Thousand | - | - |
| Cash at beginning of period | 7.94 Million | 1.83 Million | 36.74 Thousand | 1660.00 | 158.21 Thousand |
| Cash at end of period | 124.57 Thousand | 7.94 Million | 1.83 Million | 36.74 Thousand | 1660.00 |
| Capital Expenditure | -1552.00 | -1999.00 | - | -4251.00 | - |
| Effect of forex changes on cash | 67.84 Thousand | -19.26 Thousand | -32.09 Thousand | -23.97 Thousand | -6871.00 |
| Net cash flow / Change in cash | -7.81 Million | 6.11 Million | 1.79 Million | 35.08 Thousand | -156.55 Thousand |
| Free Cash Flow | -8.12 Million | -11.42 Million | -2.52 Million | -2.12 Million | -747.31 Thousand |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.92 Million | -2.67 Million | -1.83 Million | -11.71 Million | -1.89 Million | -3.31 Million |
| Depreciation & Amortization | 334.00 | 231.00 | 231.00 | 1728.00 | 306.00 | 582.00 |
| Deferred income taxes | - | - | -3.23 Billion | - | - | - |
| Stock-based compensation | 78.1 Thousand | 78.1 Thousand | 78.1 Thousand | 351.72 Thousand | 83.55 Thousand | 95.02 Thousand |
| Change in working capital | 1.84 Million | 1.84 Million | 1.33 Million | 3.23 Million | 963.09 Thousand | 348.43 Thousand |
| Other non-cash items | - | - | 3.23 Billion | - | - | - |
| Investing Cash Flow | - | - | -1.55 Million | -1552.00 | - | - |
| Investments in PPE | - | - | -1.55 Million | -1552.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -44.68 Thousand | 2.01 Million | 241.94 Thousand | 241.94 Thousand | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -44.68 Thousand | 2.01 Million | - | - | - | - |
| Other Financing Activities | - | 899.5 Million | 241.94 Thousand | 241.94 Thousand | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | 1.86 Billion | 3 Billion | 3 Billion | - | 236.93 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.84 Million | -1.86 Billion | -3 Billion | -3 Billion | - | 111.5 Thousand |
| Cash at beginning of period | 1.4 Million | 124.57 Thousand | 310.82 Thousand | 7.94 Million | 1.15 Million | 3.97 Million |
| Cash at end of period | 362.09 Thousand | 1.4 Million | 124.57 Thousand | 124.57 Thousand | 310.82 Thousand | 1.15 Million |
| Capital Expenditure | - | - | -1.55 Million | -1552.00 | - | - |
| Effect of forex changes on cash | 14.52 Thousand | 17.33 Thousand | -6287.00 | 67.84 Thousand | 6010.00 | 57.22 Thousand |
| Net cash flow / Change in cash | -1.03 Million | 1.27 Million | -186.24 Thousand | -7.81 Million | -845.64 Thousand | -2.81 Million |
| Free Cash Flow | -1 Million | -759.85 Thousand | -1.97 Million | -8.12 Million | -851.65 Thousand | -2.87 Million |
FLEXITUFF
8529
BEEP
VTSI
600392
2139